SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mirror Image who wrote (1680)2/9/2016 2:27:51 PM
From: eico20  Read Replies (1) of 2026
 
what's most interesting is they are going for changes on both cold and room temp devices,
starting with the cold temp I presume soon,


Goals and Priorities for 2016
Apricus expects to obtain European approval for one or more variations to the approved Vitaros product with the goal of enhancing the profile of Vitaros;

As per Nov 5 PR: “Continue to generate the required data to support regulatory submission(s) in 2016 for the refrigerated and room temperature delivery devices.”

As per today’s PR: “Apricus expects to obtain European approval for one or more variations to the approved Vitaros product with the goal of enhancing the profile of Vitaros;”

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News